The Medsintez Plant took part in the training seminar Topical Issues of Healthcare, which was held on April 25 at the I.M. Sechenov First Moscow State Medical University. The event was attended by over 500 people – heads of healthcare management bodies headed by the Minister of Healthcare of the Russian Federation Mikhail Murashko.
From April 11 to April 14, the fourth International specialized exhibition-forum Healthcare of the Urals – 2023 was held at the Ekaterinburg-Expo IEC, where the Medsintez Plant traditionally presented its products at the booth. The focus this year was on equipping the medical system in the regions of Russia. The focus on import independence in the current conditions also remains one of the key ones. 160 manufacturers and suppliers of medical products from 30 cities of Russia, which presented over a thousand pieces of various equipment, took part in the event.
On January 31, 2023, a TASS press conference was held dedicated to the joint scientific and technological developments of the Ural State Medical University and industrial enterprises of the Sverdlovsk Region. The results of the implementation of the Priority 2030 program in 2022, the cooperation of the university with industrial enterprises of the region, as well as the project for creation of a full-cycle scientific and educational complex for the manufacture of medicines were discussed by Olga Kovtun, rector of USMU, Anatoly Sludnykh, General Director of the Ural Optical and Mechanical Plant, and Alexander Petrov, Chairman of the Board of Directors of the Medsintez Plant.
On November 26, 2022, the Medsintez Plant took part in the Scientific and Practical Conference of Pediatric Endocrinologists of the Sverdlovsk Region From Clinical Cases to Innovative Projects, dedicated to the 25th anniversary of the endocrinology department of the Regional Children's Clinical Hospital. Leading experts of Russia in the field of healthcare and endocrinology took part in the conference. At the exhibition of domestic pharmaceutical manufacturers, held within the framework of the conference, the Medsintez Plant presented analogue human insulin preparations Rosinsulin®. Doctors – pediatric endocrinologists and endocrinologists of healthcare organizations of the Sverdlovsk Region, the Ural Federal District and other regions of Russia noted the plant's contribution to the drug safety of the country.
On November 19, 2022, the Medsintez Plant, which has the highest FSH production capacity in the world, held a grand opening of the workshop for the production of biotechnological substances for women's reproductive health. Since 2018, the Medsintez Plant, in cooperation with iVFarma, has been producing the first Russian preparation of recombinant follicle-stimulating hormone (FSH) for the treatment of human infertility – Primapur®. The Medsintez Plant produces the substance of this drug and the finished dosage form in pre-filled disposable syringe pens.
Этот сайт использует файлы cookie для хранения данных. Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами. Вы можете отказаться от использования cookies, выбрав соответствующие настройки в браузере.
